Report Library
View More
Depression KOL Interview - Germany
September 18, 2025
Key Potential Drug Launches in 2026
September 17, 2025
Datamonitor Healthcare CV&Met: Isch...
September 15, 2025
Datamonitor Healthcare CV&Met: Veno...
September 15, 2025
Datamonitor Healthcare I&I: Systemi...
September 15, 2025
Datamonitor Healthcare CV&Met: Chem...
September 15, 2025
Datamonitor Healthcare Oncology: Gl...
September 15, 2025
Datamonitor Healthcare Other: Erect...
September 15, 2025
Datamonitor Healthcare Other: Hypog...
September 15, 2025
Datamonitor Healthcare CV&Met: Amyl...
September 15, 2025
Datamonitor Healthcare Oncology: Tu...
September 15, 2025
Datamonitor Healthcare Oncology: Sm...
September 15, 2025
Datamonitor Healthcare CNS: Neuropa...
September 15, 2025
Datamonitor Healthcare Oncology: Me...
September 15, 2025
Datamonitor Healthcare I&I: Glaucom...
September 15, 2025
Datamonitor Healthcare Oncology Dis...
September 12, 2025
Datamonitor Healthcare I&I Disease ...
September 12, 2025
Datamonitor Healthcare CV&Met Disea...
September 10, 2025
Dealmaking Quarterly Statistics, Q2...
September 4, 2025
Financing Quarterly Statistics, Q2 ...
September 4, 2025
Impact Events
More| Date | Lead Company | Event | Type | Approval Change | Approval Likelihood |
|---|---|---|---|---|---|
| 9/17/25 | AstraZeneca (AZN) | Fasenra for Chronic Obstructive Pulmonary Disease (COPD) | Subscribers Only | Subscribers Only | Subscribers Only |
| 9/17/25 | Eli Lilly (LLY) | Orforglipron for Diabetes Mellitus, Type II | Subscribers Only | Subscribers Only | Subscribers Only |
| 9/17/25 | Eli Lilly (LLY) | Mounjaro for Diabetes Mellitus, Type II | Subscribers Only | Subscribers Only | Subscribers Only |
| 9/17/25 | Regeneron Pharmaceuticals (REGN) | Garetosmab for Fibrodysplasia Ossificans Progressiva (FOP) | Subscribers Only | Subscribers Only | Subscribers Only |
| 9/16/25 | SK Biopharmaceuticals (A326030) | Xcopri for Tonic-Clonic Seizures (Epilepsy) | Subscribers Only | Subscribers Only | Subscribers Only |
Upcoming Catalysts
More| Expected Date Range | Lead Company | Drug | Expected Catalyst |
|---|---|---|---|
| 06/25/2025 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
| 06/25/2025 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
| 06/26/2025 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
| 06/30/2025 | Subscribers Only | Subscribers Only | Trial Data - Updated Results |
| 09/08/2025 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |